Ventolin and Rash papular - a phase IV clinical study of FDA data

Summary:

Rash papular is reported as a side effect among people who take Ventolin (albuterol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Spiriva, and have Hypersensitivity.

The phase IV clinical study analyzes which people have Rash papular when taking Ventolin. It is created by eHealthMe based on reports of 50,731 people who have side effects when taking Ventolin from the FDA, and is updated regularly.

What is Ventolin?

Ventolin has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 51,849 Ventolin users. Check the latest studies of Ventolin.

What is Rash papular?

Rash papular (redness with papule) is found to be associated with 1,131 drugs and 1,329 conditions by eHealthMe. Check the latest studies of Rash papular.

On Jul, 08, 2026

50,731 people reported to have side effects when taking Ventolin.
Among them, 50 people (0.1%) have Rash papular.

Among these 50 people:

How long have people been on Ventolin when they have Rash papular? *

What is the gender of people who have Rash papular when taking Ventolin? *

female: 67.35 %
male: 32.65 %

What is the age of people who have Rash papular when taking Ventolin? *

What are other drugs people take besides Ventolin? *

What are other side effects people have besides Rash papular? *

Itching: 17 people, 34.00%
Rashes (redness): 11 people, 22.00%
Dyspnea (difficult or laboured breathing): 9 people, 18.00%
Rash Pruritic (redness with itching): 8 people, 16.00%
Pain: 8 people, 16.00%
Urticaria (rash of round, red welts on the skin that itch intensely): 7 people, 14.00%
Weakness: 5 people, 10.00%
Dry Skin: 5 people, 10.00%
Skin Discoloration: 5 people, 10.00%
Oedema (fluid collection in tissue): 4 people, 8.00%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 10.00%
Back Pain: 5 people, 10.00%
Hypersensitivity: 5 people, 10.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.00%
High Blood Pressure: 3 people, 6.00%
Breast Cancer: 3 people, 6.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 6.00%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 3 people, 6.00%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 3 people, 6.00%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ventolin and have Rash papular?

- Check whether Rash papular is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ventolin:

Ventolin (51,849 reports)

Rash papular treatments and more:

Rash papular (25,753 reports)

Browse all side effects of Ventolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash papular:

Rash papular (1,131 drugs)

Browse all the conditions that are associated with Rash papular:

Rash papular (1,329 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol (the active ingredients of Ventolin) and Ventolin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.